Evidence map›Paper›PMID 30183706›Full record

ArticlePloS one2018

Breast cancer subtype and survival among Indigenous American women in Peru.

Lizeth I Tamayo, Tatiana Vidaurre, Jeannie Navarro Vásquez, Sandro Casavilca, Jessica I Aramburu Palomino, Monica Calderon, Julio E Abugattas, Henry L Gomez, Carlos A Castaneda, Sikai Song and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Lizeth I TamayoDivision of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, Illinois, United States of America.ORCID 0000-0002-2417-3331
Tatiana VidaurreInstituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Jeannie Navarro VásquezInstituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Sandro CasavilcaInstituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Jessica I Aramburu PalominoInstituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Monica CalderonInstituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Julio E AbugattasInstituto Nacional de Enfermedades Neoplásicas, Lima, Perú.ORCID 0000-0002-9806-0989
Henry L GomezInstituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Carlos A CastanedaInstituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Sikai SongDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Daniel CherryDepartment of Medicine, University of California San Diego, San Diego, California, United States of America.
Garth H RauscherDivision of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Laura FejermanDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.ORCID 0000-0003-3179-1151
Instituto Nacional de Enfermedades Neoplásicas · PEUniversity of California, San Francisco · USUniversity of Illinois Chicago · USUniversity of California San Diego · US

Funding

Biological implications of breast cancer protective variants in Latin Americanwomen with high Indigenous American ancestryR01CA204797 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEJERMAN, LAURA · 2016 to 2020
$1.9M
6 · The paper itself

Abstract

Latina women in the U.S. have relatively low breast cancer incidence compared to Non-Latina White (NLW) or African American women but are more likely to be diagnosed with the more aggressive "triple negative" breast cancer (TNBC). Latinos in the U.S. are a heterogeneous group originating from different countries with different cultural and ancestral backgrounds. Little is known about the distribution of tumor subtypes in Latin American regions. Clinical records of 303 female Peruvian patients, from the Peruvian National Cancer Institute, were analyzed. Participants were diagnosed with invasive breast cancer between 2010 and 2015 and were identified as residing in either the Selva or Sierra region. We used Fisher's exact test for proportions and multivariable Cox Proportional Hazards Models to compare overall survival between regions. Women from the Selva region were more likely to be diagnosed with TNBC than women from the Sierra region (31% vs. 14%, p = 0.01). In the unadjusted Cox model, the hazard of mortality was 1.7 times higher in women from the Selva than the Sierra (p = 0.025); this survival difference appeared to be largely explained by differences in the prevalence of TNBC. Our results suggest that the distribution of breast cancer subtypes differs between highly Indigenous American women from two regions of Peru. Disentangling the factors that contribute to this difference will add valuable information to better target prevention and treatment efforts in Peru and improve our understanding of TNBC among all women. This study demonstrates the need for larger datasets of Latin American patients to address differences between Latino subpopulations and optimize targeted prevention and treatment.

Indexed as

AdultAgedDisease-Free SurvivalFemaleHumansIncidenceMiddle AgedPeruSurvival RateTriple Negative Breast Neoplasms

Identifiers

PMID30183706
PMCPMC6124707
OpenAlexW2890253514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.